Selected research
Industry Research
Porcine Circovirus Diseases Vaccine Industry Research Report 2026
Market perspective
The global Porcine Circovirus Diseases Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Porcine Circovirus Diseases Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Porcine Circovirus Diseases Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Porcine Circovirus Diseases Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Porcine Circovirus Diseases Vaccine include Zoetis, Yebio Bioengineering, Pulike Biological Engineering, Nannong Hi-Tech, Merck, Jinyu Bio-technology, Jinhe Biotechnology, Hile Bio-Technology and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Porcine Circovirus Diseases Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Porcine Circovirus Diseases Vaccine Market by Company
Zoetis
Yebio Bioengineering
Pulike Biological Engineering
Nannong Hi-Tech
Merck
Jinyu Bio-technology
Jinhe Biotechnology
Hile Bio-Technology
Ceva
Boehringer Ingelheim
Porcine Circovirus Diseases Vaccine Segment by Type
Inactivated Vaccine
Genetically Engineered Vaccine
Porcine Circovirus Diseases Vaccine Segment by Application
Piglet
Fertile Sow
Porcine Circovirus Diseases Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Circovirus Diseases Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Porcine Circovirus Diseases Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Circovirus Diseases Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Porcine Circovirus Diseases Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Porcine Circovirus Diseases Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Porcine Circovirus Diseases Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Inactivated Vaccine
- Genetically Engineered Vaccine
Applications
- Piglet
- Fertile Sow
Companies covered
- Zoetis
- Yebio Bioengineering
- Pulike Biological Engineering
- Nannong Hi-Tech
- Merck
- Jinyu Bio-technology
- Jinhe Biotechnology
- Hile Bio-Technology
- Ceva
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Porcine Circovirus Diseases Vaccine Market Size (2021-2032)
- 2.2.2 Global Porcine Circovirus Diseases Vaccine Sales (2021-2032)
- 2.2.3 Global Porcine Circovirus Diseases Vaccine Market Average Price (2021-2032)
- 2.3 Porcine Circovirus Diseases Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Inactivated Vaccine
- 2.3.3 Genetically Engineered Vaccine
- 2.4 Porcine Circovirus Diseases Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Piglet
- 2.4.3 Fertile Sow
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Porcine Circovirus Diseases Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Porcine Circovirus Diseases Vaccine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Porcine Circovirus Diseases Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Porcine Circovirus Diseases Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Porcine Circovirus Diseases Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Porcine Circovirus Diseases Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Porcine Circovirus Diseases Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Porcine Circovirus Diseases Vaccine, Established Date
- 3.9 Global Porcine Circovirus Diseases Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Yebio Bioengineering
- 4.2.1 Yebio Bioengineering Company Information
- 4.2.2 Yebio Bioengineering Business Overview
- 4.2.3 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yebio Bioengineering Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.2.5 Yebio Bioengineering Recent Developments
- 4.3 Pulike Biological Engineering
- 4.3.1 Pulike Biological Engineering Company Information
- 4.3.2 Pulike Biological Engineering Business Overview
- 4.3.3 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pulike Biological Engineering Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.3.5 Pulike Biological Engineering Recent Developments
- 4.4 Nannong Hi-Tech
- 4.4.1 Nannong Hi-Tech Company Information
- 4.4.2 Nannong Hi-Tech Business Overview
- 4.4.3 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nannong Hi-Tech Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.4.5 Nannong Hi-Tech Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.5.5 Merck Recent Developments
- 4.6 Jinyu Bio-technology
- 4.6.1 Jinyu Bio-technology Company Information
- 4.6.2 Jinyu Bio-technology Business Overview
- 4.6.3 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jinyu Bio-technology Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.6.5 Jinyu Bio-technology Recent Developments
- 4.7 Jinhe Biotechnology
- 4.7.1 Jinhe Biotechnology Company Information
- 4.7.2 Jinhe Biotechnology Business Overview
- 4.7.3 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jinhe Biotechnology Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.7.5 Jinhe Biotechnology Recent Developments
- 4.8 Hile Bio-Technology
- 4.8.1 Hile Bio-Technology Company Information
- 4.8.2 Hile Bio-Technology Business Overview
- 4.8.3 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hile Bio-Technology Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.8.5 Hile Bio-Technology Recent Developments
- 4.9 Ceva
- 4.9.1 Ceva Company Information
- 4.9.2 Ceva Business Overview
- 4.9.3 Ceva Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ceva Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.9.5 Ceva Recent Developments
- 4.10 Boehringer Ingelheim
- 4.10.1 Boehringer Ingelheim Company Information
- 4.10.2 Boehringer Ingelheim Business Overview
- 4.10.3 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Boehringer Ingelheim Porcine Circovirus Diseases Vaccine Product Portfolio
- 4.10.5 Boehringer Ingelheim Recent Developments
5 Global Porcine Circovirus Diseases Vaccine Market Scenario by Region
- 5.1 Global Porcine Circovirus Diseases Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Porcine Circovirus Diseases Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Porcine Circovirus Diseases Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Porcine Circovirus Diseases Vaccine Sales by Region: 2027-2032
- 5.3 Global Porcine Circovirus Diseases Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Porcine Circovirus Diseases Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Porcine Circovirus Diseases Vaccine Revenue by Region: 2027-2032
- 5.4 North America Porcine Circovirus Diseases Vaccine Market Facts & Figures by Country
- 5.4.1 North America Porcine Circovirus Diseases Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Porcine Circovirus Diseases Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Porcine Circovirus Diseases Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Porcine Circovirus Diseases Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Porcine Circovirus Diseases Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Porcine Circovirus Diseases Vaccine Market Facts & Figures by Country
- 5.7.1 South America Porcine Circovirus Diseases Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Porcine Circovirus Diseases Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Porcine Circovirus Diseases Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Porcine Circovirus Diseases Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Porcine Circovirus Diseases Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Porcine Circovirus Diseases Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Porcine Circovirus Diseases Vaccine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Porcine Circovirus Diseases Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Porcine Circovirus Diseases Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Porcine Circovirus Diseases Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Porcine Circovirus Diseases Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Porcine Circovirus Diseases Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Porcine Circovirus Diseases Vaccine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Porcine Circovirus Diseases Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Porcine Circovirus Diseases Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Porcine Circovirus Diseases Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Porcine Circovirus Diseases Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Porcine Circovirus Diseases Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Porcine Circovirus Diseases Vaccine Value Chain Analysis
- 8.1.1 Porcine Circovirus Diseases Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Porcine Circovirus Diseases Vaccine Production Mode & Process
- 8.2 Porcine Circovirus Diseases Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Porcine Circovirus Diseases Vaccine Distributors
- 8.2.3 Porcine Circovirus Diseases Vaccine Customers
9 Global Porcine Circovirus Diseases Vaccine Analyzing Market Dynamics
- 9.1 Porcine Circovirus Diseases Vaccine Industry Trends
- 9.2 Porcine Circovirus Diseases Vaccine Industry Drivers
- 9.3 Porcine Circovirus Diseases Vaccine Industry Opportunities and Challenges
- 9.4 Porcine Circovirus Diseases Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst